Updated Equity Valuation report on Square Pharmaceuticals Limited

Categories: Industry/Sector Analysis, Fundamental Analysis, Equity Investments

Country or region: Bangladesh

Summary:
The Pharmaceuticals industry of Bangladesh is expected to grow  at  a  CAGR  of  15%  over  the  next  five  years  due  to steady  economic  growth,  population  growth,  growth  of income  level  of  people  and  increased  health  awareness. Being  the  leader  in  the  growing pharmaceuticals  industry; Square Pharmaceuticals Limited is expected to grow at the same pace with the industry.

Date of original publication:

02/08/2018


Statistics
Total Views: 494
Total Downloads: 48

Share Article

Reader Comments

No comments made on this post yet

Note

If you have any copyright and other associated infringements related to this item, please click on the Terms and Conditions link where you will be directed to the Digital Millennium Copyright Act (DCMA) that will outline the procedure for raising your concern.

If you have any concerns with the content of the item [e.g., offensive language and/or material, inappropriate material] then please proceed to utilize the Contact Us form. Remember that when using the Contact Us form, please ensure you reference/cite clearly the item in question (e.g., name of article, author(s) of article) and the nature of the complaint.

Categories